Cas:866252-52-0 4,5-Dimethoxy-2-(trimethylsilyl)phenyl Trifluoromethanesulfonate manufacturer & supplier

Chemical Name:4,5-Dimethoxy-2-(trimethylsilyl)phenyl Trifluoromethanesulfonate

CAS.NO:866252-52-0

Synonyms:Methanesulfonic acid, 1,1,1-trifluoro-, 4,5-dimethoxy-2-(trimethylsilyl)phenyl ester;4,5-Dimethoxy-2-(trimethylsilyl)phenyl trifluoromethanesulfonate;(4,5-dimethoxy-2-trimethylsilylphenyl) trifluoromethanesulfonate

Molecular Formula:C₁₂H₁₇F₃O₅SSi

Molecular Weight:358.406

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:350.1±42.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.473

PSA:70.21000

Exact Mass:358.051819

LogP:5.10

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:3265

Packing Group:II

Contact us for information like Methanesulfonic acid, 1,1,1-trifluoro-, 4,5-dimethoxy-2-(trimethylsilyl)phenyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4,5-dimethoxy-2-trimethylsilylphenyl) trifluoromethanesulfonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methanesulfonic acid, 1,1,1-trifluoro-, 4,5-dimethoxy-2-(trimethylsilyl)phenyl ester Use and application,Methanesulfonic acid, 1,1,1-trifluoro-, 4,5-dimethoxy-2-(trimethylsilyl)phenyl ester technical grade,usp/ep/jp grade.

Related News: Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. ethyl 4-amino-8-chloro-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxylate manufacturers OTL-101, by comparison, is designed to correct the problem by inserting working copies of the gene into a patient’s blood stem cells. (Z)-1-(1-(4-bromophenyl)prop-1-en-1-yl)pyrrolidine suppliers There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% Os(PMe2Ph)3(N3)2 vendor & factory.